Veterinary Therapeutics Market Enhancement, and Business Opportunities from 2023 to 2029 by Key Players | Virbac , Bayer AG , Merial , IDEXX Laboratories

The report titled Veterinary Therapeutics Market report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends,  policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. It also examines the role of the leading market players involved in the industry including their opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding and SWOT analysis. Our analysts monitoring the global situation explain that the market will offer lucrative prospects for producers in the wake of the COVID-19 crisis. The report aims to further illustrate the latest situation, economic slowdown and the impact of COVID-19 on the industry as a whole.

Veterinary Therapeutics Market is growing at a +7.2% CAGR during the forecast period 2023-2029. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Download Sample Report PDF (Including Full TOC, Table & Figures):

https://www.marketintelligencedata.com/reports/8318846/global-veterinary-therapeutics-market-research-report-2023-impact-of-covid-19-on-the-market/inquiry?Mode=S74

Veterinary Therapeutics Market: Overview

Veterinary therapeutics is a branch of animal healthcare that deals with prevention, treatment, and alleviation of several diseases. The veterinary therapeutics market consists of drugs for the treatment of animal diseases, vaccines for the prevention of various pathological conditions, and feed additives to maintain the overall well-being of animals by providing all the necessary nutrients required to lead a long, healthy life.
The drugs segment includes anti-infective, anti-inflammatory, parasiticides, and others. Different types of vaccines such as inactivated vaccine, live attenuated vaccine, recombinant vaccine, and others are used in the treatment of veterinary disorders.
Global demand for veterinary drugs, vaccines, and medicated feed additives to prevent, treat, and manage different animal diseases has reached an all-time high. Rapid increase in number of animal diseases, rise in companion animal ownership, and high prevalence of zoonotic diseases have fueled the demand for high quality veterinary therapeutics. According to the National Pet Owners Survey, conducted by American Pet Products Association (APPA), in 2017, around 68% of households in the U.S. owned a companion animal or pet.
Moreover, increase in investments in research & development of novel drugs and vaccines by private and government bodies is also expected to propel the market in the near future
However, low research and development (R&D) returns resulting in aging product portfolio, stringent regulatory framework, and rising concern about the use of antibiotics and growth promoters in food animals are some of the restraints of the veterinary therapeutics market

Key Players in This Report Include:

Virbac, Bayer AG, Merial, IDEXX Laboratories, Inc., Boehringer Ingelheim International GmbH, Intervet Inc. (Merck Animal Health), Elanco, Ceva, Vetoquinol S.A., Zoetis

Industry News:

IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio

WESTBROOK, Maine, June 15, 2023 - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the first veterinary diagnostic test for detecting kidney injury in cats and dogs. According to a recent IDEXX survey, as many as one-third of kidney cases seen by veterinarians are related to kidney injury, and a diagnosis can be challenging due to subtle or nonspecific signs.1 The IDEXX Cystatin B Test will be included in test panels assessing renal health, uncovering new clinical insights for an estimated two million patient visits annually. These tests will be run at IDEXX Reference Laboratories starting later this year in the U.S. and Canada, with plans to introduce the test in Europe in 2024.

Westlake, TX / Wilmington, NC - Virbac is proud to announce the launch of its first product in the U.S. food production animal market with the FDA approval of Tulissin® 25 (tulathromycin injection) injectable solution and Tulissin® 100 (tulathromycin injection) injectable solution for use in cattle and swine. The product will be available in two concentrations: 100 mg/mL and 25 mg/mL to properly cover the two segments. Tulissin 100 injectable solution will be available in 500, 250, 100 and 50 mL bottles and Tulissin 25 Injectable Solution in 250 and 100 mL bottles.

In June 2021, Zoetis Inc., declared that it will extend its portfolio of equine horse care products, with the inclusion of Pro-Stride® APS, Restigen® PRP and CenTrate® BMA, a series of devices planned to assist address injuries typical in horses that may bring about lameness. Equine lameness as an outcome of musculoskeletal pain, specifically osteoarthritis, is one of the top reasons for veterinary assessment and can have considerable physical, economic and quality-of-life effect to both horse and owner. Horse joint health care is an increasingly significant segment in equine medicine.

The Veterinary Therapeutics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market, opportunities and upcoming challenges and about the competitors.

The Veterinary Therapeutics Market segments and Market Data Break Down are illuminated below

By Type:

 Surgery

Drugs

Vaccines

Feed Additives

Others

By Application:

Veterinary Hospitals

Veterinary Clinics

Pharmacies & Drug Stores

Others

Following are the various regions covered by the Veterinary Therapeutics Market research report:

North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Russia, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, and Rest of APAC), South America (Brazil, Argentina, Columbia and Rest of Latin America), Middle East & Africa (Saudi Arabia, South Africa, Turkey, Nigeria, UAE and Rest of MEA)

Regional Overview: Veterinary Therapeutics Market

In terms of region, the global veterinary therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
The current and future market value in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report, with their CAGRs from 2023 to 2029
The study also offers a list of recommendations, highlights, and useful insights of the market which would help new companies willing to enter the market and existing companies to increase market shares and decision-making process

Have a query? Market an enquiry before purchase:

https://www.marketintelligencedata.com/reports/8318846/global-veterinary-therapeutics-market-research-report-2023-impact-of-covid-19-on-the-market?Mode=S74

Objectives of the Report

To carefully analyses and forecast the size of the market by value and volume.
To estimate the market shares of major segments of the Veterinary Therapeutics
To showcase the development of the market in different parts of the world.
To analyze and study micro-markets in terms of their contributions to the Veterinary Therapeutics market, their prospects, and individual growth trends.
To offer precise and useful details about factors affecting the growth of the Veterinary Therapeutics
To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Veterinary Therapeutics market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Key Points Covered in Market Report:

Chapter 1: Market Overview, Definition and Classification Market drivers and barriers

Chapter 2: Market Competition by Key Players

Chapter 3: Impact Analysis of COVID-19 on Market

Chapter 4: Market Capacity, Production, Revenue (Value) by region (2023-2029)

Chapter 5: Veterinary Therapeutics Supply (Production), Consumption, Export, Import by Region (2023-2029)

Chapter 6: Veterinary Therapeutics market Production, Revenue (Value), Price Trend by Type

Chapter 7:  Payment Gateway, Merchant Account, Subscription Management

Chapter 8: Veterinary Therapeutics Manufacturers Profiles/Analysis & Manufacturing Cost Analysis, Industrial/Supply Chain Analysis, Sourcing Strategy and Downstream Buyers, Marketing

Chapter 9: Strategy by Key Manufacturers/Players, Connected Distributors/Traders Chapter1: Chapter 10: Standardization, Regulatory and collaborative initiatives, Industry Road map and value chain Market Effect Factors Analysis.

Key questions answered in this report:

What is the size of the Veterinary Therapeutics market and what is its expected growth rate?
What are the primary driving factors that push the Veterinary Therapeutics market forward?
What are the Veterinary Therapeutics Industry's top companies?
What are the different categories that the Veterinary Therapeutics Market caters to?
What will be the fastest-growing segment or region?
In the value chain, what role do essential players play?
What is the procedure for getting a free copy of the Veterinary Therapeutics market sample report and company profiles?

Buy Now Link:

https://www.marketintelligencedata.com/report/purchase/8318846?mode=su?Mode=S74

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will recognize how the Veterinary Therapeutics market scenario changed across the globe during the pandemic, post-pandemic, and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transference, consumer behaviour, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. These factors negatively affected the market during the war."

We offer customization on the Veterinary Therapeutics market report based on specific client requirements:

25% free customization.
5 Countries can be added as per your choice.
5 Companies can add as per your choice.
Free customization for up to 40 hours.
After-sales support for 1 year from the date of delivery.

Thank you for your interest in the Veterinary Therapeutics Market research publications; you can also get individual chapters or regional/country report versions such as Germany, France, China, Latin America, GCC, North America, Europe or Asia.

About Us:
Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact us:

Irfan Tamboli (Head of Sales) - market intelligence data

Phone: +1 (704) 266-3234 | +91-750-707-8687

Mail to: sales@marketintelligencedata.com

This release was published on openPR.